- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05199857
WE BEAT - HEART Club Fontan Wellness Project: A Virtual Resilience Promotion and Frailty Prevention Program
This trial is being conducted to evaluate the effect of a small-group wellness education program combined with a longitudinal, individualized prescription exercise program on the wellness, resiliency, and daily activity levels of pediatric patients with Fontan physiology.
There will be two phases for this project. The first phase is the "WE BEAT Group Wellness Education Program" and participants will be transitioned into the phase two HEART Club following phase one.
The trial will look at feasibility and acceptability of the program. Additional hypothesis include home whether exercise interventions can:
- be delivered without any associated serious cardiac events;
- will result in a decreased proportion of patients who are categorized as frail when compared to the cohort's pre-test baseline.
- will result in increased measured peak oxygen consumption when compared with their pre-intervention baseline.
- will result in increased step counts measured monthly from baseline to end of intervention
- will improve self-reported quality of life from baseline to post-intervention.
- will result in increased patient reported activity level from baseline to post-intervention
Study Overview
Status
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Males and females with Fontan physiology who are 13 to <19 years of age at enrollment
- Own a mobile device capable of installing the University of Michigan Patient Portal application
- Fluent in English
- Participant consent or parental/guardian consent and participant assent
Exclusion Criteria:
- Height < 130 centimeters
- Current intravenous inotropic drugs
- Severe ventricular dysfunction assessed qualitatively by clinical echocardiography within six months prior to enrollment.
- Severe valvar regurgitation, ventricular outflow obstruction, or aortic arch obstruction assessed by clinical echocardiography within six months prior to enrollment.
- History of arrhythmia with exercise (excluding isolated supraventricular or ventricular ectopy without symptoms).
- Inability to complete exercise testing at baseline screening.
- Noncardiac medical, developmental, and/or social disorder that would prevent successful completion of planned study testing or would invalidate its results.
- Suicidality or homicidality in the past 6 months.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Wellness education and Home exercise programs
|
Participants will be assigned into a small group with 3-6 other participants and will participate in a weekly, 45-50 minute intervention session for 5 weeks, delivered by a licensed clinical psychologist or limited licensed clinical psychology fellow using University of Michigan (UM) Zoom.
Each session will focus on a particular skill related to wellness and resiliency.
There will also be a short battery of questionnaires to complete.
This is an individualized home exercise program adapted from the exercise programs used in traditional, hospital-based cardiac rehabilitation.
A complete cardiopulmonary exercise test (CPET) may be completed if needed for a baseline and one will be done at the last visit.
The exercise physiology team will discuss participants exercise goals, interests, and available resources to help develop the exercise plan for the research study.
Once the program is designed, participants will complete the exercise activities in the plan.
Over time, participants will advance through various stages in the program and then will be gradually introduced to the principles of exercise rehabilitation and more intense physical exercise.
Participants will be asked to wear a wearable activity tracker and have scheduled video check-ins with the exercise physiology team.
Throughout the program participants will complete a short battery of surveys.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in the Connor-Davidson Resilience Scale 10
Time Frame: baseline, 6 weeks
|
This is a 10 item self-report rating scale 0 (not true at all) to 4 (true nearly all the time).
The overall score range from 0 (no resilience) to 40 (high Resilience).
|
baseline, 6 weeks
|
|
Change in the Lurz-Wilde pediatric frailty score
Time Frame: baseline (prior to home exercise start), after exercise program (6 months)
|
The Lurz-Wilde Frailty score is the sum of points scored across 5 domains of physical and mental functioning (weakness, slowness, shrinkage, exhaustion, diminished physical activity).
The maximum score is 10.
If a patient accumulates > 5 points, they are considered frail.
If a patient accumulates 4-5 points, they are considered pre-frail.
|
baseline (prior to home exercise start), after exercise program (6 months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility of the 2-phase intervention based on recruitment information - number of participants that are: approached, eligible, enrolled
Time Frame: up to approximately 18 months
|
up to approximately 18 months
|
|
|
Feasibility of the 2-phase intervention based on sociodemographic data including: self-reported race, ethnicity, household income, and education level of primary caregiver
Time Frame: up to approximately 18 months
|
up to approximately 18 months
|
|
|
Feasibility of the home exercise intervention program based on the number of adverse events (AEs) Categorized by relatedness to the intervention
Time Frame: 6 months
|
|
6 months
|
|
Change in the Patient Reported Outcome Measures Information System (PROMIS) pediatric physical activity -short form 4a
Time Frame: baseline (prior to home exercise start), after exercise program (6 months)
|
This is a 4-item questionnaire that asks participants about their level of physical activity in the past 7 days.
Items are scored on a 5-point scale.
Scores range from 4 to 20 with 4 indicating low physical activity and 20 indicating high physical activity (better outcome).
|
baseline (prior to home exercise start), after exercise program (6 months)
|
|
Change in the Patient-Reported Outcomes Measurement Information System Pediatric Profile-25 2.0 (PROMIS-25)
Time Frame: baseline (prior to home exercise start), after exercise program (6 months)
|
PROMIS-25 measures quality of life (i.e., depression, anxiety, and pain interference).
The 25 items are on a 1-5 scale and are scored using the Health Measures Scoring Service with higher scores indicating a lower quality of life.
|
baseline (prior to home exercise start), after exercise program (6 months)
|
|
Seven day running average step counts
Time Frame: baseline (week 1 of exercise program), last week of exercise program (6 months)
|
baseline (week 1 of exercise program), last week of exercise program (6 months)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Jesse Hansen, MD, University of Michigan
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HUM00205931
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Frailty
-
University of PennsylvaniaCompleted
-
McMaster UniversityRecruitingFrailty | Frailty Syndrome | Frail Older Adults | Frailty in AgingCanada
-
University of IcelandLandspitali University HospitalRecruitingFrailty Syndrome | Elective Surgery | Frailty in Adult SurgeryIceland
-
Universidad Francisco de VitoriaNot yet recruitingFrailty Syndrome | Respiratory Muscle Weakness | Age-Related Frailty | Geriatric Health
-
Universidad Francisco de VitoriaActive, not recruitingFrailty Syndrome | Respiratory Muscle Weakness | Age-Related Frailty | Geriatric HealthSpain
-
Ji Yan Biomedical Co., Ltd.YC Biotech Co., Ltd.Not yet recruiting
-
Universidad Francisco de VitoriaNot yet recruitingFrailty Syndrome | Respiratory Muscle Weakness | Age-Related Frailty | Geriatric Health
-
University of NottinghamRecruitingFrailty | Diet | Systemic Inflammatory Response | Dietary Fiber | Frailty at Older Adults | Pre-FrailtyUnited Kingdom
-
National Taipei University of Nursing and Health...Not yet recruiting
-
IRCCS Centro San Giovanni di Dio FatebenefratelliCompleted
Clinical Trials on WE BEAT Group Wellness Education program - phase 1
-
Universidad de La FronteraCompletedCoronary Artery Disease | Acute Coronary SyndromeChile
-
Wake Forest University Health SciencesNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Castilla-La Mancha Health ServiceColegio Oficial de Terapeutas Ocupacionales de Castilla - La Mancha; Fundación... and other collaboratorsActive, not recruiting
-
Centre Hospitalier Universitaire de NīmesCompleted
-
Ohio State University Comprehensive Cancer CenterAmerican Cancer Society, Inc.RecruitingBreast Carcinoma | Cervical Carcinoma | Colorectal CarcinomaUnited States